232 related articles for article (PubMed ID: 23316863)
21. Generation and characterization of aptamers targeting factor XIa.
Woodruff RS; Ivanov I; Verhamme IM; Sun MF; Gailani D; Sullenger BA
Thromb Res; 2017 Aug; 156():134-141. PubMed ID: 28644959
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor.
Navaneetham D; Sinha D; Walsh PN
J Biochem; 2010 Oct; 148(4):467-79. PubMed ID: 20647553
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in the discovery and development of factor XI/XIa inhibitors.
Al-Horani RA; Afosah DK
Med Res Rev; 2018 Sep; 38(6):1974-2023. PubMed ID: 29727017
[TBL] [Abstract][Full Text] [Related]
24. Lignosulfonic Acid Sodium Is a Noncompetitive Inhibitor of Human Factor XIa.
Kar S; Bankston P; Afosah DK; Al-Horani RA
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577586
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Chromen-7-yl Furan-2-Carboxylate as a Potent and Selective Factor XIa Inhibitor.
Obaidullah AJ; Al-Horani RA
Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):40-48. PubMed ID: 28552062
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212).
Pinto DJP; Orwat MJ; Smith LM; Quan ML; Lam PYS; Rossi KA; Apedo A; Bozarth JM; Wu Y; Zheng JJ; Xin B; Toussaint N; Stetsko P; Gudmundsson O; Maxwell B; Crain EJ; Wong PC; Lou Z; Harper TW; Chacko SA; Myers JE; Sheriff S; Zhang H; Hou X; Mathur A; Seiffert DA; Wexler RR; Luettgen JM; Ewing WR
J Med Chem; 2017 Dec; 60(23):9703-9723. PubMed ID: 29077405
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of novel proline based factor XIa selective inhibitors as leads for potential new anticoagulants.
Hussain Z; Cooke AJ; Neelamkavil S; Brown L; Carswell E; Geissler WM; Guo Z; Hawes B; Kelly TM; Kiyoi Y; Lai K; Lesburg C; Pow E; Zang Y; Wood HB; Edmondson SD; Liu W
Bioorg Med Chem Lett; 2020 Aug; 30(16):127072. PubMed ID: 32340773
[TBL] [Abstract][Full Text] [Related]
28. Potent, Selective, Allosteric Inhibition of Human Plasmin by Sulfated Non-Saccharide Glycosaminoglycan Mimetics.
Afosah DK; Al-Horani RA; Sankaranarayanan NV; Desai UR
J Med Chem; 2017 Jan; 60(2):641-657. PubMed ID: 27976897
[TBL] [Abstract][Full Text] [Related]
29. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.
Rezaie AR; Sun MF; Gailani D
Biochemistry; 2006 Aug; 45(31):9427-33. PubMed ID: 16878977
[TBL] [Abstract][Full Text] [Related]
30. Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency.
Corte JR; Yang W; Fang T; Wang Y; Osuna H; Lai A; Ewing WR; Rossi KA; Myers JE; Sheriff S; Lou Z; Zheng JJ; Harper TW; Bozarth JM; Wu Y; Luettgen JM; Seiffert DA; Quan ML; Wexler RR; Lam PYS
Bioorg Med Chem Lett; 2017 Aug; 27(16):3833-3839. PubMed ID: 28687203
[TBL] [Abstract][Full Text] [Related]
31. Purification of factor XIa inhibitor from human platelets.
Komiyama Y; Murakami T; Egawa H; Okubo S; Yasunaga K; Murata K
Thromb Res; 1992 May; 66(4):397-408. PubMed ID: 1412206
[TBL] [Abstract][Full Text] [Related]
32. Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa.
Donkor DA; Bhakta V; Eltringham-Smith LJ; Stafford AR; Weitz JI; Sheffield WP
Sci Rep; 2017 May; 7(1):2102. PubMed ID: 28522812
[TBL] [Abstract][Full Text] [Related]
33. Progress curve analysis of the kinetics with which blood coagulation factor XIa is inhibited by protease nexin-2.
Scandura JM; Zhang Y; Van Nostrand WE; Walsh PN
Biochemistry; 1997 Jan; 36(2):412-20. PubMed ID: 9003194
[TBL] [Abstract][Full Text] [Related]
34. Influence of low molecular weight heparin and low molecular weight dextran sulfate on the inhibition of coagulation factor XIa by serpins.
Mauron T; Lämmle B; Wuillemin WA
Thromb Haemost; 1998 Jul; 80(1):82-6. PubMed ID: 9684790
[TBL] [Abstract][Full Text] [Related]
35. Macromolecular substrate-binding exosites on both the heavy and light chains of factor XIa mediate the formation of the Michaelis complex required for factor IX-activation.
Sinha D; Marcinkiewicz M; Navaneetham D; Walsh PN
Biochemistry; 2007 Aug; 46(34):9830-9. PubMed ID: 17676929
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor.
Wuillemin WA; Minnema M; Meijers JC; Roem D; Eerenberg AJ; Nuijens JH; ten Cate H; Hack CE
Blood; 1995 Mar; 85(6):1517-26. PubMed ID: 7534133
[TBL] [Abstract][Full Text] [Related]
37. Fragment-Based Lead Generation of 5-Phenyl-1
Wei Q; Zheng Z; Zhang S; Zheng X; Meng F; Yuan J; Xu Y; Huang C
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103465
[TBL] [Abstract][Full Text] [Related]
38. Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa.
Wuillemin WA; Eldering E; Citarella F; de Ruig CP; ten Cate H; Hack CE
J Biol Chem; 1996 May; 271(22):12913-8. PubMed ID: 8662679
[TBL] [Abstract][Full Text] [Related]
39. Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups.
Corte JR; Pinto DJP; Fang T; Osuna H; Yang W; Wang Y; Lai A; Clark CG; Sun JH; Rampulla R; Mathur A; Kaspady M; Neithnadka PR; Li YC; Rossi KA; Myers JE; Sheriff S; Lou Z; Harper TW; Huang C; Zheng JJ; Bozarth JM; Wu Y; Wong PC; Crain EJ; Seiffert DA; Luettgen JM; Lam PYS; Wexler RR; Ewing WR
J Med Chem; 2020 Jan; 63(2):784-803. PubMed ID: 31833761
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa.
Lazarova TI; Jin L; Rynkiewicz M; Gorga JC; Bibbins F; Meyers HV; Babine R; Strickler J
Bioorg Med Chem Lett; 2006 Oct; 16(19):5022-7. PubMed ID: 16876411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
